MS Pharma Establishes MENA's First Biologics Manufacturing Hub in Saudi Arabia, Advancing Regional Leadership and Global Partnerships

MS Pharma inaugurates Middle East's first biologics manufacturing facility in Saudi Arabia, SFDA-approved and built to meet EMA and FDA standards.Specialized in monoclonal antibodies and complex peptides, with in-house bioanalytical labs.Strategic platform for global partners, enabling localized and contract manufacturing access to MENA, EU, and US markets.View original content:https://www.prnewswire.co.uk/news-releases/ms-pharma-establishes-menas-first-biologics-manufacturing-hub-in-saudi-arabia-advancing-regional-leadership-and-global-partnerships-302539994.html